GALECTIN THERAPEUTICS INC. Temporary Equity, Aggregate Amount of Redemption Requirement
GALECTIN THERAPEUTICS INC. (GALT) had Temporary Equity, Aggregate Amount of Redemption Requirement of $7.97 billion as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Temporary Equity › Temporary Equity, Other Disclosure
us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement · last filed 2026-08-14
- 2026-06-30: Temporary Equity, Aggregate Amount of Redemption Requirement $7.97B.
- 2026-03-31: Temporary Equity, Aggregate Amount of Redemption Requirement $7.97B.
- 2025-12-31: Temporary Equity, Aggregate Amount of Redemption Requirement $7.97B.
- 2025-09-30: Temporary Equity, Aggregate Amount of Redemption Requirement $8.02B.
| Period end | Temporary Equity, Aggregate Amount of Redemption Requirement |
|---|---|
| 2026-06-30 | $7.97B 10-Q · filed 2026-08-14 |
| 2026-03-31 | $7.97B 10-Q · filed 2026-05-15 |
| 2025-12-31 | $7.97B 10-K · filed 2026-03-31 |
| 2025-09-30 | $8.02B 10-Q · filed 2025-11-14 |
| 2025-06-30 | $8.02B 10-Q · filed 2025-08-14 |
| 2025-03-31 | $7.94B 10-Q · filed 2025-05-15 |
| 2024-12-31 | $8.02M 10-K · filed 2025-03-31 |
| 2024-09-30 | $8.12M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $8.12M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $8.10M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $8.18M 10-K · filed 2024-03-29 |
| 2023-09-30 | $8.20M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $8.28M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $8.26M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $8.34M 10-K · filed 2023-03-30 |
| 2022-09-30 | $8.31M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $8.39M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $8.36M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $8.44M 10-K · filed 2022-03-31 |
| 2021-09-30 | $8.41M 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |